Perlara, PBC is precision drug discovery that leaves no mutation behind.
Perlara has raised $1.7M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
Perlara's investors include Y Combinator, Slow Ventures, Homebrew, Travere Therapeutics, Techammer.
Perlara is headquartered in San Francisco, United States.
Perlara, PBC is precision drug discovery that leaves no mutation behind.
Perlara is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Perlara — Funding & Investors." VCBacked, October 7, 2025, https://www.vcbacked.co/company/perlara. Accessed October 17, 2026.
VCBacked. (2025). Perlara — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/perlara
{{cite web |title=Perlara — Funding & Investors |url=https://www.vcbacked.co/company/perlara |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated